Michael C. Greiner's most recent trade in Avanos Medical Inc was a trade of 19,771 Common Stock done at an average price of $12.4 . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | Michael C. Greiner | Former Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.43 per share. | 13 May 2025 | 19,771 | 204,493 (0%) | 0% | 12.4 | 245,754 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Former Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.43 per share. | 13 May 2025 | 4,474 | 200,019 (0%) | 0% | 12.4 | 55,612 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 73,633 | 73,633 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 34,316 | 224,264 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 8,485 | 189,948 (0%) | 0% | 15.3 | 129,821 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 5,112 | 198,433 (0%) | 0% | 15.3 | 78,214 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 12,149 | 214,235 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 6,048 | 208,187 (0%) | 0% | 15.1 | 91,506 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 4,642 | 203,545 (0%) | 0% | 15.1 | 70,233 | Common Stock |
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | 03 Dec 2024 | 10,000 | 200,898 (0%) | 0% | 0 | Common Stock | ||
| Avanos Medical Inc | Michael C. Greiner | Interim CEO | 29 Oct 2024 | 44,189 | 190,898 (0%) | 0% | 0 | Common Stock | ||
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 18 Mar 2024 | 7,113 | 146,709 (0%) | 0% | 19.1 | 135,787 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 18 Mar 2024 | 4,219 | 155,714 (0%) | 0% | 0 | Common Stock | ||
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 18 Mar 2024 | 1,892 | 153,822 (0%) | 0% | 19.1 | 36,118 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 3,800 | 155,695 (0%) | 0% | 19.1 | 72,618 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 2,231 | 152,750 (0%) | 0% | 19.1 | 42,679 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 808 | 151,605 (0%) | 0% | 19.1 | 15,473 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 714 | 154,981 (0%) | 0% | 19.1 | 13,652 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 337 | 152,413 (0%) | 0% | 19.1 | 6,450 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 14 Mar 2024 | 110 | 151,495 (0%) | 0% | 19.2 | 2,108 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 06 Mar 2024 | 57,471 | 164,613 (0%) | 0% | 19.1 | 1,099,995 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 06 Mar 2024 | 5,118 | 159,495 (0%) | 0% | 19 | 97,242 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 05 Mar 2024 | 4,991 | 106,312 (0%) | 0% | 18.8 | 93,631 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 08 May 2023 | 14,710 | 111,303 (0%) | 0% | 24.0 | 352,599 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 06 Mar 2023 | 34,619 | 129,050 (0%) | 0% | 0 | Common Stock | ||
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 06 Mar 2023 | 3,037 | 126,013 (0%) | 0% | 29.6 | 89,956 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 03 Jan 2023 | 4,726 | 93,765 (0%) | 0% | 27.1 | 127,886 | Common Stock | |
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 04 Mar 2022 | 30,575 | 98,491 (0%) | 0% | 0 | Common Stock | ||
| Avanos Medical Inc | Michael C. Greiner | SVP - Chief Financial Officer | 17 Mar 2021 | 15,861 | 67,244 (0%) | 0% | 47.3 | 750,067 | Common Stock |